| SYS | | c018984 |
|---|
| LBL | | ^^^^^nam^^22^^^^^^^^450^ |
|---|
| 005 | | 20010517145322.0 |
|---|
| 100 | | $a 19970530d1997 u y0sloc0103 ba |
|---|
| 101 | 0- | $a eng |
|---|
| 102 | | $a US |
|---|
| 105 | | $a y z 100yy |
|---|
| 200 | 1- | $a Moving points in pediatric nephrology and transplantation $e proceedings of the 6th annual workshop of the North American pediatric renal transplant cooperative study, March 1996 $f edit. Amir Tejani, Mohamed Sayegh |
|---|
| 210 | | $a Malden $c Blackwell Science $d 1997 |
|---|
| 215 | | $a 117 s. |
|---|
| 225 | 2- | $a Kidney International $v Suppl. No. 58 $x 0098-6577 |
|---|
| 541 | 1- | $a Pálčivé problémy v pediatrickej nefrológii a transplantácii $z slo |
|---|
| 606 | | $a nefrológia $2 mesh $3 sllk_un_auth*d009398 |
|---|
| 606 | | $a pediatria $2 mesh $3 sllk_un_auth*d010372 |
|---|
| 606 | | $a transplantácia obličky $x dieťa $2 mesh $3 sllk_un_auth*d016030 |
|---|
| 606 | | $a antigény HLA $2 mesh $3 sllk_un_auth*d006680 |
|---|
| 606 | | $a antigény CD28 $2 mesh $3 sllk_un_auth*d018106 |
|---|
| 606 | | $a rejekcia štepu $2 mesh $3 sllk_un_auth*d006084 |
|---|
| 606 | | $3 sllk_un_auth*d003226 $a kongresy ako téma $y Spojené štáty americké $y Washington $2 mesh |
|---|
| 606 | | $a transplantácia heterológna $2 mesh $3 sllk_un_auth*d014183 |
|---|
| 606 | | $a etika lekárska $2 mesh $3 sllk_un_auth*d004992 |
|---|
| 606 | | $a glomerulonefritída $2 mesh $3 sllk_un_auth*d005921 |
|---|
| 606 | | $a proteinúria $2 mesh $3 sllk_un_auth*d011507 |
|---|
| 606 | | $a nefritída dedičná $2 mesh $3 sllk_un_auth*d009394 |
|---|
| 606 | | $a syndróm nefrotický $x dieťa $2 mesh $3 sllk_un_auth*d009404 |
|---|
| 606 | | $a edém $x terapia $2 mesh $3 sllk_un_auth*d004487 |
|---|
| 606 | | $3 sllk_un_auth*d005923 $a glomeruloskleróza fokálna segmentálna $x dieťa $2 mesh |
|---|
| 606 | | $a cyklosporín $x použitie terapeutické $2 mesh $3 sllk_un_auth*d016572 |
|---|
| 606 | | $a syndróm hemolyticko-uremický $x dieťa $2 mesh $3 sllk_un_auth*d006463 |
|---|
| 606 | | $a acidóza $2 mesh $3 sllk_un_auth*d000138 |
|---|
| 606 | | $a urémia $2 mesh $3 sllk_un_auth*d014511 |
|---|
| 606 | | $a zlyhanie obličiek, chronické $x dieťa $2 mesh $3 sllk_un_auth*d007676 |
|---|
| 606 | | $3 sllk_un_auth*d011948 $a receptory T-buniek, antigénové $2 mesh |
|---|
| 606 | | $a antigény HLA $2 mesh $3 sllk_un_auth*d006680 |
|---|
| 675 | | $a 616.61-053.2+616-089.843-053.2(061.3) $v 1. stred. $z slo |
|---|
| 702 | -1 | $a Tejani $b Amir $3 sllk_un_auth*p0004688 $4 340 |
|---|
| 702 | -1 | $a Sayegh $b Mohamed $3 sllk_un_auth*p0004689 $4 340 |
|---|
| 710 | 02 | $3 sllk_un_auth*k0000194 $a International Society of Nephrology $4 070 |
|---|
| 801 | -0 | $a SK $b BA006 $c 19981223 $g AACR2 |
|---|
